Prof. Borowiak received her MSc degree with distinction from Adam Mickiewicz University. She then pursued her PhD studies at the Max-Delbrück Center for Molecular Medicine, where she focused on liver regeneration under the guidance of Prof. Carmen Birchmeier. She received her PhD degree with honors from the Free University of Berlin, Germany. After completing her doctoral studies, Prof. Borowiak moved to Harvard University in Cambridge, MA, USA for postdoctoral research, where she worked with Prof. Doug Melton on the application of human pluripotent stem cells and chemical biology in regenerative medicine.

She established her research group as an Assistant Professor and McNair Scholar in Medicine at Baylor College of Medicine in Houston, TX, USA, Prof. Borowiak led a research program on pancreatic cell fate determination and the molecular basis of atypical diabetes using mouse genetics, human pluripotent stem cells, gene editing, and different omics approaches at both population and single cell levels. Her team’s findings have been published in renowned scientific journals such as Nature, Cell Stem Cell, Nature Biotechnology, Science Advances, Cell Reports, and Nature Communications, among others.

Prof. Borowiak is currently directing the stem cell and regenerative medicine program at Adam Mickiewicz University in Poznan, where she continues her work on modeling metabolic diseases and human pancreas development. She has received funding from numerous sources, including the McNair Medical Institute, National Institute of Health, JDRF, Helmsley Foundation, Polish Foundation of Science, EU-Horizon, and Polish National Science Center. Additionally, Prof. Borowiak has three patents licensed to biotech companies and is recognized as an innovator in her field.